150 related articles for article (PubMed ID: 33073681)
21. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
[No Abstract] [Full Text] [Related]
22. Long Non-Coding RNA Differentiation Antagonizing Nonprotein Coding RNA (DANCR) Promotes Proliferation and Invasion of Pancreatic Cancer by Sponging miR-214-5p to Regulate E2F2 Expression.
Yao Z; Chen Q; Ni Z; Zhou L; Wang Y; Yang Y; Huang H
Med Sci Monit; 2019 Jun; 25():4544-4552. PubMed ID: 31213582
[TBL] [Abstract][Full Text] [Related]
23. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
24. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
25. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J
Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512
[TBL] [Abstract][Full Text] [Related]
26. miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer.
Zang W; Wang Y; Wang T; Du Y; Chen X; Li M; Zhao G
Mol Cancer; 2015 Feb; 14():37. PubMed ID: 25744894
[TBL] [Abstract][Full Text] [Related]
27. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
Mou T; Xie F; Zhong P; Hua H; Lai L; Yang Q; Wang J
Biomed Pharmacother; 2019 Mar; 111():891-900. PubMed ID: 30841468
[TBL] [Abstract][Full Text] [Related]
28. [miRNA-191-5p represses cell growth by targeting CDK6 in gastric cancer].
Cao NJ; Hou HH; Li F; Guo ST; Wang Y
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(46):3689-3693. PubMed ID: 33342146
[No Abstract] [Full Text] [Related]
29. microRNA-1225 inhibit apoptosis of pancreatic cancer cells via targeting JAK1.
Zhong R; Li S; Fang K; Yang L; Wang L
Cell Cycle; 2019 May; 18(9):990-1000. PubMed ID: 30990343
[TBL] [Abstract][Full Text] [Related]
30. Role of miR-214-5p in the migration and invasion of pancreatic cancer cells.
Cao TH; Ling X; Chen C; Tang W; Hu DM; Yin GJ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7214-7221. PubMed ID: 30468464
[TBL] [Abstract][Full Text] [Related]
31. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
Xiao G; Wang P; Zheng X; Liu D; Sun X
Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
[TBL] [Abstract][Full Text] [Related]
32. nc-RNA-mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer.
Zhao YX; Xu BW; Wang FQ; Jiang FY; Xu JW; Yu DX
Cancer Med; 2023 Feb; 12(4):5110-5123. PubMed ID: 36457244
[TBL] [Abstract][Full Text] [Related]
33. MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway.
Zhu JH; De Mello RA; Yan QL; Wang JW; Chen Y; Ye QH; Wang ZJ; Tang HJ; Huang T
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165747. PubMed ID: 32109492
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
[TBL] [Abstract][Full Text] [Related]
35. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
Zhao G; Yin Y; Zhao B
J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
[TBL] [Abstract][Full Text] [Related]
36. ΜiR-182-5p functions as a tumor suppressor to sensitize human ovarian cancer cells to cisplatin through direct targeting the cyclin dependent kinase 6 (CDK6).
Duan L; Yan Y; Wang G; Xing YL; Sun J; Wang LL
J BUON; 2020; 25(5):2279-2286. PubMed ID: 33277846
[TBL] [Abstract][Full Text] [Related]
37. miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3.
Qiu Z; Wang X; Shi Y; Da M
Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):997-1007. PubMed ID: 31518383
[TBL] [Abstract][Full Text] [Related]
38. The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer.
Jia Y; Zhao LM; Bai HY; Zhang C; Dai SL; Lv HL; Shan BE
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30530570
[TBL] [Abstract][Full Text] [Related]
39. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
40. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
